Europe Cannabis Industry & Marijuana Business News

New data reveals top medical conditions for which cannabis is reimbursed in Germany

The German government disclosed the six most-reported diagnoses for which medical cannabis has been prescribed and covered by statutory health insurers (GKV), with pain No. 1 followed by a muscle condition known as spasticity. The data is based on an ongoing government survey involving 6,538 patients, as of September. The information was disclosed in a reply to a […]

Read More

Netherlands consults businesses on recreational cannabis experiment

The Dutch Ministry of Health, Welfare and Sport opened a public consultation process seeking feedback on the proposed rules for a “controlled cannabis supply chain experiment,” also called wietexperiment (weed experiment) by authorities. At the end of August, 10 Dutch municipalities with 79 coffee shops were selected to be given access to a legal supply of recreational marijuana […]

Read More

France creates committee to draft rules for medical cannabis trial

The French Agency for the Safety of Medicines and Health Products (ANSM) created a scientific committee to write certain rules ahead of the launch of a two-year medical cannabis experiment. The areas of focus of the committee will be: The products that will become available to patients during the trial. The training of doctors and pharmacists who will […]

Read More

France appears ready to OK funding for a medical cannabis experiment with 3,000 patients

French lawmakers appear ready to approve legislation to bankroll a two-year medical cannabis trial program for 3,000 patients, a move that would give overseas companies the opportunity to export product to what could become one of Europe’s largest markets. Olivier Véran, deputy of the French National Assembly, submitted an amendment to the Social Security Financing Bill (Projet de […]

Read More

German cannabis firm Demecan secures 7 million euros in financing

German medical cannabis company Demecan has secured 7 million euros ($7.6 million) in financing to expand production in Europe’s largest medical market. The fresh capital – from btov Partners, a European venture capital firm, and a German single family office – comes as international companies establish footholds in the important European Union market. Constantin von der Groeben, Demecan’s managing director, […]

Read More

Auxly Cannabis closes CA$123 million investment from tobacco giant Imperial Brands

Auxly Cannabis finalized an investment from Imperial Brands worth 123 million Canadian dollars ($92 million), one of the largest investments yet from a tobacco company in the marijuana industry. The British multinational tobacco company picks up a 19.9% stake in British Columbia-based Auxly as part of the deal. In return, Auxly gets licenses for Imperial’s […]

Read More

European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says

The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age and older. The CBD-based medicine was greenlighted in Europe […]

Read More

Netherlands to experiment with nonmedical marijuana commercial production

Coffee shops in 10 Dutch municipalities will have access to a legal supply of recreational marijuana for the first time, the Dutch Ministry of Health, Welfare and Sport announced. In the Netherlands, sales of recreational marijuana in coffee shops has been tolerated under certain conditions, but production and supply has remained illegal. Now, companies will be […]

Read More

Germany gets first cannabis samples from Australia, commercial import from Portugal

It’s a big week for Germany’s medical marijuana market, which received its first cannabis imports from Australia and Portugal. Frankfurt-based Cansativa took delivery of medical cannabis oils for testing purposes from Western Australia-based Little Green Pharma. Cannamedical Pharma of Cologne received a shipment of commercial medical cannabis from an unidentified Portugal company. However, Tilray Portgual announced […]

Read More

Cannabis firm Atlas expands to Denmark, plans large indoor production

Edmonton, Alberta-based Atlas Biotechnologies is expanding to Denmark, where the Canadian producer plans to repurpose a sprawling indoor mushroom farm for medical cannabis cultivation. The initiative, expected to cost 40 million-50 million Canadian dollars ($27 million-$37 million), aims to be fully operational by the end of 2020. Atlas follows in the footsteps of Canada-based international […]

Read More